Mark A. Sirgo, Director at 9 METERS BIOPHARMA, INC. (NMTR), bought 50,000 shares at $0.89 ($45K) on 2021-12-02, disclosed to the SEC on 2021-12-03.
Open-market purchase of $44k NMTR by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| BDSI | BUY | 2021-12-06 | $50K | — | Filing → |
| NMTR | BUY | 2021-11-22 | $21K | — | Filing → |
| BDSI | BUY | 2021-11-19 | $30K | — | Filing → |